Harrow (HROW) EBITDA Margin (QoQ) (2013 - 2026)
Harrow (HROW) EBITDA Margin (QoQ) (2013 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Haleon | 43.98 Bn | 43.02 Bn | - |
| 2 | Teva Pharmaceutical Industries | 43.07 Bn | 39.42 Bn | 2.15 Bn |
| 3 | Zoetis | 31.53 Bn | 29.85 Bn | 1.05 Bn |
| 4 | Takeda Pharmaceutical | 28.60 Bn | 22.80 Bn | 5.10 Bn |
| 5 | United Therapeutics | 22.13 Bn | 19.47 Bn | 683.80 Mn |
| 6 | Viatris | 18.75 Bn | 17.86 Bn | 1.46 Bn |
| 7 | Neurocrine Biosciences | 15.53 Bn | 15.14 Bn | 935.80 Mn |
| 8 | Elanco Animal Health | 11.69 Bn | 11.16 Bn | 798.00 Mn |
| 9 | Dr Reddys Laboratories | 10.13 Bn | 9.97 Bn | - |
| 10 | Harrow | 1.56 Bn | 1.48 Bn | 50.36 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 3,437.00 |
| Mar 31, 2026 | -6,745.00 |
| Dec 31, 2025 | -309.00 |
| Sep 30, 2025 | 269.00 |
| Jun 30, 2025 | 4,138.00 |
| Mar 31, 2025 | -4,278.00 |
| Dec 31, 2024 | 1,662.00 |
| Sep 30, 2024 | -44.00 |
| Jun 30, 2024 | 2,316.00 |
| Mar 31, 2024 | -662.00 |
| Dec 31, 2023 | -1,850.00 |
| Sep 30, 2023 | -194.00 |
| Jun 30, 2023 | 239.00 |
| Mar 31, 2023 | 1,338.00 |
| Dec 31, 2022 | -833.00 |
| Sep 30, 2022 | -766.00 |
| Jun 30, 2022 | -225.00 |
| Mar 31, 2022 | 1,819.00 |
| Dec 31, 2021 | 1,117.00 |
| Sep 30, 2021 | -4,286.00 |